Filter posts

In New Role, Former UK Prime Minister David Cameron Charts Path ‘Out of Forest’ for Alzheimer's...

Former British Prime Minister David Cameron told attendees at the 2017 BIO International Convention in …

Green Light for CAR-T Leukemia Treatment Is an Historic Moment for Biotechnology

I’ve been President and CEO of BIO for more than a dozen years, and I’ve been …

“Genomics and Personalized Medicine Empower People to Save Their Own Lives”

Wednesday morning of the 2017 BIO International Convention commenced the Personalized Medicine & Diagnostics Track …

It's a Wrap-BIO 2017 Delivers Again

Breaking all previous records, BIO 2017 hosted over 41,400 partnering meetings during this year’s event. …

Shooting for the Moon: Creating the Next Generation of Cancer Killers

The last morning of the 2017 BIO International Convention kicked off with a 9:00am oncology …

Expanded Access: New Opportunities for Patients and Sponsors

Patients with serious or life-threatening conditions may find themselves with no treatment options once approved …

Making Sense and Cents Out of Pharma Strategic Venture Investing

For most large pharmaceutical companies, strategic venture arms are no longer a “nice to have,” …

Unleashing CAR-T Therapies on Solid Tumors: Are We There Yet?

Chimeric antigen receptor (CAR) T cell therapies have shown dramatic results against certain blood cancers …

U.S. Department of Defense Officials Introduce New Strategies to Stimulate Medical Countermeasures D...

For the past several years, BIO has had the opportunity to partner with the U.S. …

Start-Up CEO: Making the Choices to Develop a Novel Medicine

The choices surrounding research investment and drug development are daunting for even the most experienced …